FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY
INVESTMENT COMPANY ACT FILE NUMBER: 811-03010
EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER: Fidelity Advisor Series VII
Fund Name: Fidelity Advisor Biotechnology Fund
82 DEVONSHIRE STREET, BOSTON, MA 02109
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
ERIC D. ROITER, SECRETARY, 82 DEVONSHIRE STREET, BOSTON, MA 02109
(NAME AND ADDRESS OF AGENT FOR SERVICE)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: 617-563-7000
DATE OF FISCAL YEAR END: JULY 31
DATE OF REPORTING PERIOD: 06/30/2007
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE INVESTMENT COMPANY ACT OF 1940, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED, THERE UNTO DULY AUTHORIZED.
Fidelity Advisor Series VII
BY: /s/ KIMBERLEY MONASTERIO*
KIMBERLEY MONASTERIO, TREASURER
DATE: 08/10/2007 08:02:51 PM
*BY: /s/ CLAIRE S. WALPOLE
CLAIRE S. WALPOLE, VICE PRESIDENT, FIDELITY MANAGEMENT & RESEARCH COMPANY, PURSUANT TO A POWER OF ATTORNEY DATED JULY 10, 2007 AND FILED HEREWITH.
VOTE SUMMARY REPORT
Fidelity Advisor Biotechnology Fund
07/01/2006- 06/30/2007
Note: The Security ID will be the CUSIP (Committee on Uniform Securities Identification Procedures) when available. When CUSIP is not available, an alternate identifier, e.g., CINS, will be provided.
| ISSUER NAME: ACADIA PHARMACEUTICALS INC. MEETING DATE: 06/15/2007 | ||||
| TICKER: ACAD SECURITY ID: 004225108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT GORDON BINDER AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT LESLIE L. IVERSEN AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ACORDA THERAPEUTICS, INC. MEETING DATE: 06/05/2007 | ||||
| TICKER: ACOR SECURITY ID: 00484M106 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT SANDRA PANEM, PH.D. AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT WISE YOUNG, PH.D., M.D AS A DIRECTOR | Management | For | Withhold |
| 2 | TO RATIFY THE APPOINTMENT OF KPMG LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| 3 | TO TRANSACT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENT THEREOF. | Management | For | Abstain |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: AFFYMAX, INC. MEETING DATE: 05/31/2007 | ||||
| TICKER: AFFY SECURITY ID: 00826A109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT KATHLEEN LAPORTE AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ELIZABETH A. CZEREPAK AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF AFFYMAX FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: AKORN, INC. MEETING DATE: 05/24/2007 | ||||
| TICKER: AKRX SECURITY ID: 009728106 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JOHN N. KAPOOR, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ARTHUR S. PRZYBYL AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JERRY N. ELLIS AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT RONALD M. JOHNSON AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT JERRY I. TREPPEL AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT SUBHASH KAPRE, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT RANDALL J. WALL AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE SELECTION OF BDO SEIDMAN, LLP TO SERVE AS AKORN S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ALEXION PHARMACEUTICALS, INC. MEETING DATE: 05/03/2007 | ||||
| TICKER: ALXN SECURITY ID: 015351109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT LEONARD BELL AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT DAVID W. KEISER AS A DIRECTOR | Management | For | Withhold |
| 1. 3 | ELECT MAX LINK AS A DIRECTOR | Management | For | Withhold |
| 1. 4 | ELECT JOSEPH A. MADRI AS A DIRECTOR | Management | For | Withhold |
| 1. 5 | ELECT LARRY L. MATHIS AS A DIRECTOR | Management | For | Withhold |
| 1. 6 | ELECT R. DOUGLAS NORBY AS A DIRECTOR | Management | For | Withhold |
| 1. 7 | ELECT ALVIN S. PARVEN AS A DIRECTOR | Management | For | Withhold |
| 1. 8 | ELECT RUEDI E. WAEGER AS A DIRECTOR | Management | For | Withhold |
| 2 | APPROVAL OF THE AMENDMENT TO 2004 INCENTIVE PLAN, AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT, INCLUDING TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE BY 1.2 MILLION SHARES (SUBJECT TO ADJUSTMENT IN THE EVENT OF STOCK SPLITS AND OTHER SIMILAR EVENTS). | Management | For | For |
| 3 | RATIFICATION OF APPOINTMENT BY THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ALKERMES, INC. MEETING DATE: 09/21/2006 | ||||
| TICKER: ALKS SECURITY ID: 01642T108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT FLOYD E. BLOOM AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ROBERT A. BREYER AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT GERRI HENWOOD AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT PAUL J. MITCHELL AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT RICHARD F. POPS AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT ALEXANDER RICH AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT PAUL SCHIMMEL AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT MARK B. SKALETSKY AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT MICHAEL A. WALL AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN AMENDMENT TO THE 1999 STOCK OPTION PLAN TO INCREASE THE NUMBER OF SHARES ISSUABLE UPON EXERCISE OF OPTIONS GRANTED THEREUNDER, BY 1,000,000 SHARES. | Management | For | For |
| 3 | TO APPROVE AN AMENDMENT TO THE 2002 RESTRICTED STOCK AWARD PLAN TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE THEREUNDER, BY 300,000 SHARES. | Management | For | Against |
| 4 | TO APPROVE THE 2006 STOCK OPTION PLAN FOR NON-EMPLOYEE DIRECTORS WHICH PROVIDES FOR THE ISSUANCE OF OPTIONS TO ACQUIRE UP TO 240,000 SHARES OF COMMON STOCK OF THE COMPANY. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ALNYLAM PHARMACEUTICALS, INC. MEETING DATE: 06/01/2007 | ||||
| TICKER: ALNY SECURITY ID: 02043Q107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT VICTOR J. DZAU, M.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT KEVIN P. STARR AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT BY THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ALTUS PHARMACEUTICALS, INC. MEETING DATE: 07/27/2006 | ||||
| TICKER: ALTU SECURITY ID: 02216N105 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JOHN P. RICHARD AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT STEWART HEN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT HARRY H. PENNER, JR. AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE SELECTION OF DELOITTE & TOUCHE LLP AS INDEPENDENT AUDITORS FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ALTUS PHARMACEUTICALS, INC. MEETING DATE: 06/27/2007 | ||||
| TICKER: ALTU SECURITY ID: 02216N105 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JONATHAN S. LEFF* AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT DAVID D. PENDERGAST* AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JONATHAN D. ROOT* AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE SELECTION OF DELOITTE & TOUCHE LLP AS INDEPENDENT AUDITORS FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: AMGEN INC. MEETING DATE: 05/09/2007 | ||||
| TICKER: AMGN SECURITY ID: 031162100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | ELECTION OF DIRECTOR: MR. FRANK J. BIONDI, JR. | Management | For | For |
| 2 | ELECTION OF DIRECTOR: MR. JERRY D. CHOATE | Management | For | For |
| 3 | ELECTION OF DIRECTOR: MR. FRANK C. HERRINGER | Management | For | For |
| 4 | ELECTION OF DIRECTOR: DR. GILBERT S. OMENN | Management | For | For |
| 5 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| 6 | TO APPROVE THE AMENDMENTS TO THE COMPANY S RESTATED CERTIFICATE OF INCORPORATION ELIMINATING THE CLASSIFICATION OF THE BOARD OF DIRECTORS. | Management | For | For |
| 7 | TO APPROVE THE AMENDMENTS TO THE COMPANY S AMENDED AND RESTATED BYLAWS ELIMINATING THE CLASSIFICATION OF THE BOARD OF DIRECTORS. | Management | For | For |
| 8 | STOCKHOLDER PROPOSAL #1 (ANIMAL WELFARE POLICY). | Shareholder | Against | Abstain |
| 9 | STOCKHOLDER PROPOSAL #2 (SUSTAINABILITY REPORT). | Shareholder | Against | Abstain |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: AMYLIN PHARMACEUTICALS, INC. MEETING DATE: 05/23/2007 | ||||
| TICKER: AMLN SECURITY ID: 032346108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT STEVEN R. ALTMAN AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT TERESA BECK AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT DANIEL M. BRADBURY AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT JOSEPH C. COOK, JR. AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT KARIN EASTHAM AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT JAMES R. GAVIN III AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT GINGER L. GRAHAM AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT HOWARD E. GREENE, JR. AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT JAY S. SKYLER AS A DIRECTOR | Management | For | For |
| 1. 10 | ELECT JOSEPH P. SULLIVAN AS A DIRECTOR | Management | For | For |
| 1. 11 | ELECT JAMES N. WILSON AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN INCREASE OF 250,000,000 SHARES IN THE AGGREGATE NUMBER OF SHARES OF THE COMPANY S COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE COMPANY S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION. | Management | For | For |
| 3 | TO APPROVE AN INCREASE OF 1,000,000 SHARES IN THE AGGREGATE NUMBER OF SHARES OF THE COMPANY S COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE COMPANY S 2001 EMPLOYEE STOCK PURCHASE PLAN. | Management | For | For |
| 4 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: APPLERA CORPORATION MEETING DATE: 10/19/2006 | ||||
| TICKER: ABI SECURITY ID: 038020103 | ||||
| TICKER: CRA SECURITY ID: 038020202 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT RICHARD H. AYERS AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT JEAN-LUC BELINGARD AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ROBERT H. HAYES AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT ARNOLD J. LEVINE AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT WILLIAM H. LONGFIELD AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT THEODORE E. MARTIN AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT CAROLYN W. SLAYMAN AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT ORIN R. SMITH AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT JAMES R. TOBIN AS A DIRECTOR | Management | For | For |
| 1. 10 | ELECT TONY L. WHITE AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2007. | Management | For | For |
| 3 | APPROVAL OF AMENDMENTS TO THE APPLERA CORPORATION RESTATED CERTIFICATE OF INCORPORATION. | Management | For | For |
| 4 | APPROVAL OF AMENDMENTS TO THE APPLERA CORPORATION/APPLIED BIOSYSTEMS GROUP AMENDED AND RESTATED 1999 STOCK INCENTIVE PLAN. | Management | For | Against |
| 5 | APPROVAL OF AMENDMENTS TO THE APPLERA CORPORATION/CELERA GENOMICS GROUP AMENDED AND RESTATED 1999 STOCK INCENTIVE PLAN. | Management | For | Against |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ARENA PHARMACEUTICALS, INC. MEETING DATE: 06/11/2007 | ||||
| TICKER: ARNA SECURITY ID: 040047102 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JACK LIEF AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT DOMINIC P. BEHAN, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT DONALD D. BELCHER AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT SCOTT H. BICE AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT HARRY F HIXSON, JR, PHD AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT J.C. LA FORCE, JR, PHD AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT TINA S. NOVA, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT CHRISTINE A. WHITE, MD AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ARIAD PHARMACEUTICALS, INC. MEETING DATE: 06/19/2007 | ||||
| TICKER: ARIA SECURITY ID: 04033A100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ATHANASE LAVIDAS, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT PETER J. NELSON AS A DIRECTOR | Management | For | For |
| 2 | THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS HAS SELECTED DELOITTE & TOUCHE LLP TO BE OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2007. THE BOARD OF DIRECTORS HAS RATIFIED THIS SELECTION. DELOITTE & TOUCHE LLP HAS SERVED AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM SINCE 1991. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: BIOGEN IDEC INC. MEETING DATE: 05/31/2007 | ||||
| TICKER: BIIB SECURITY ID: 09062X103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JAMES C. MULLEN AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT BRUCE R. ROSS AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT MARIJN E. DEKKERS AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CARDIOME PHARMA CORP. MEETING DATE: 06/11/2007 | ||||
| TICKER: CRME SECURITY ID: 14159U202 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ROBERT W. RIEDER AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT PETER W. ROBERTS AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JACKIE CLEGG AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT RICHARD M. GLICKMAN AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT HAROLD H. SHLEVIN AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT DOUGLAS G. JANZEN AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT WILLIAM L. HUNTER AS A DIRECTOR | Management | For | For |
| 2 | TO APPOINT KPMG LLP, CHARTERED ACCOUNTANTS, AS AUDITORS FOR THE CORPORATION | Management | For | For |
| 3 | TO AUTHORIZE THE DIRECTORS TO FIX THE AUDITORS REMUNERATION | Management | For | For |
| 4 | TO PASS THE ORDINARY RESOLUTION, THE FULL TEXT OF WHICH IS SET OUT IN THE INFORMATION CIRCULAR, TO RATIFY, CONFIRM AND APPROVE CERTAIN AMENDMENTS AND RELATED RESOLUTIONS RESPECTING THE CORPORATION S 2001 INCENTIVE STOCK OPTION PLAN. | Management | For | Against |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CELGENE CORPORATION MEETING DATE: 06/12/2007 | ||||
| TICKER: CELG SECURITY ID: 151020104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT SOL J. BARER, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ROBERT J. HUGIN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT MICHAEL D. CASEY AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT RODMAN L. DRAKE AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT A. HULL HAYES, JR., MD AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT GILLA KAPLAN, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT JAMES J. LOUGHLIN AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT RICHARD C.E. MORGAN AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT WALTER L. ROBB, PH.D. AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CEPHALON, INC. MEETING DATE: 05/17/2007 | ||||
| TICKER: CEPH SECURITY ID: 156708109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT FRANK BALDINO, JR., PHD AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT WILLIAM P. EGAN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT MARTYN D. GREENACRE AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT VAUGHN M. KAILIAN AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT KEVIN E. MOLEY AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT CHARLES A. SANDERS, M.D AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT GAIL R. WILENSKY, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT DENNIS L. WINGER AS A DIRECTOR | Management | For | For |
| 2 | APPROVAL OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION INCREASING THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE | Management | For | For |
| 3 | APPROVAL OF AMENDMENT TO THE 2004 EQUITY COMPENSATION PLAN INCREASING THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE | Management | For | Against |
| 4 | RATIFICATION OF APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE YEAR ENDING DECEMBER 31, 2007 | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: COMBINATORX INC MEETING DATE: 05/31/2007 | ||||
| TICKER: CRXX SECURITY ID: 20010A103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT SALLY CRAWFORD AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT MICHAEL KAUFFMAN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT RICHARD POPS AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: COUGAR BIOTECHNOLOGY, INC. MEETING DATE: 06/11/2007 | ||||
| TICKER: CGRB SECURITY ID: 222083107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT A.S. BELLDEGRUN MD FACS AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ALAN H. AUERBACH AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT LINDSAY A ROSENWALD, MD AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT HAROLD J. MEYERS AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT MICHAEL S. RICHMAN AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT R.H. ELLISON, MD, MSC AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE APPOINTMENT OF J.H. COHN LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2007 | Management | For | For |
| 3 | PROPOSAL TO RATIFY AN AMENDMENT TO THE COMPANY S 2003 STOCK OPTION PLAN | Management | For | Against |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CUBIST PHARMACEUTICALS, INC. MEETING DATE: 06/07/2007 | ||||
| TICKER: CBST SECURITY ID: 229678107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT MICHAEL W. BONNEY AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT WALTER R. MAUPAY, JR. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT SYLVIE GREGOIRE AS A DIRECTOR | Management | For | For |
| 2 | A PROPOSAL TO AMEND OUR RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 100,000,000 SHARES TO 150,000,000 SHARES. | Management | For | For |
| 3 | A PROPOSAL TO AMEND OUR AMENDED AND RESTATED 1997 EMPLOYEE STOCK PURCHASE PLAN TO EXTEND THE PLAN FOR AN ADDITIONAL TEN YEARS AND INCREASE THE NUMBER OF SHARES ISSUABLE UNDER THE PLAN BY 250,000. | Management | For | Against |
| 4 | A PROPOSAL TO AMEND OUR AMENDED AND RESTATED 2002 DIRECTORS EQUITY INCENTIVE PLAN TO ALLOW FOR THE ISSUANCE OF STOCK AWARDS AND TO INCREASE THE NUMBER OF SHARES ISSUABLE UNDER THE PLAN BY 300,000. | Management | For | Against |
| 5 | A PROPOSAL TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT AUDITOR FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CYPRESS BIOSCIENCE, INC. MEETING DATE: 06/11/2007 | ||||
| TICKER: CYPB SECURITY ID: 232674507 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ROGER L. HAWLEY AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT TINA S. NOVA AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE COMPANY S BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CYTOKINETICS, INCORPORATED MEETING DATE: 05/24/2007 | ||||
| TICKER: CYTK SECURITY ID: 23282W100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT STEPHEN DOW AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT MARK MCDADE AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT MICHAEL SCHMERTZLER AS A DIRECTOR | Management | For | For |
| 2 | SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CYTOS BIOTECHNOLOGY AG, SCHLIEREN MEETING DATE: 04/25/2007 | ||||
| TICKER: -- SECURITY ID: H1754L101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | THE PRACTICE OF SHARE BLOCKING VARIES WIDELY IN THIS MARKET. PLEASE CONTACT YOUR CLIENT SERVICE REPRESENTATIVE TO OBTAIN BLOCKING INFORMATION FOR YOUR ACCOUNTS. | N/A | N/A | N/A |
| 2 | TO VOTE IN THE UPCOMING MEETING, YOUR NAME MUST BE NOTIFIED TO THE COMPANY REGISTRAR AS BENEFICIAL OWNER BEFORE THE RECORD DATE. PLEASE ADVISE US NOW IF YOU INTEND TO VOTE. NOTE THAT THE COMPANY REGISTRAR HAS DISCRETION OVER GRANTING VOTING RIGHTS. ONCE THE AGENDA IS AVAILABLE, A SECOND NOTIFICATION WILL BE ISSUED REQUESTING YOUR VOTING INSTRUCTIONS | Management | Unknown | Take No Action |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: CYTOS BIOTECHNOLOGY AG, SCHLIEREN MEETING DATE: 04/25/2007 | ||||
| TICKER: -- SECURITY ID: H1754L101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | THE PRACTICE OF SHARE BLOCKING VARIES WIDELY IN THIS MARKET. PLEASE CONTACT YOUR CLIENT SERVICE REPRESENTATIVE TO OBTAIN BLOCKING INFORMATION FOR YOUR ACCOUNTS. | N/A | N/A | N/A |
| 2 | PLEASE NOTE THAT THIS IS THE PART II OF THE MEETING NOTICE SENT UNDER MEETING367021, INCLUDING THE AGENDA. TO VOTE IN THE UPCOMING MEETING, YOUR NAME MUST BE NOTIFIED TO THE COMPANY REGISTRAR AS BENEFICIAL OWNER BEFORE THE RE-REGISTRATION DEADLINE. PLEASE NOTE THAT THOSE INSTRUCTIONS THAT ARE SUBMITTED AFTER THE CUTOFF DATE WILL BE PROCESSED ON A BEST EFFORT BASIS. THANK YOU. | N/A | N/A | N/A |
| 3 | RECEIVE THE ANNUAL REPORT, THE ANNUAL FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS FOR 2006 AND ACKNOWLEDGE THE REPORTS OF THE AUDITOR AND THE GROUP AUDITOR | Management | Unknown | Take No Action |
| 4 | APPROVE THE APPROPRIATION OF BALANCE SHEET LOSS | Management | Unknown | Take No Action |
| 5 | GRANT DISCHARGE TO THE BOARD OF DIRECTORS AND THE MANAGEMENT | Management | Unknown | Take No Action |
| 6 | APPROVE THE EXTENSION OF AUTHORIZED CAPITAL OF CHF 100,000 | Management | Unknown | Take No Action |
| 7 | APPROVE TO INCREASE THE CONDITIONAL SHARE CAPITAL OF CHF 20,000 | Management | Unknown | Take No Action |
| 8 | RE-ELECT DR. FRANCOIS L. EPLATTENIER AS A MEMBER OF THE BOARD OF DIRECTORS | Management | Unknown | Take No Action |
| 9 | RE-ELECT DR. WOLFGANG A. RENNER AS A MEMBERS OF THE BOARD OF DIRECTORS | Management | Unknown | Take No Action |
| 10 | ELECT THE AUDITOR AND THE GROUP AUDITOR | Management | Unknown | Take No Action |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: DENDREON CORPORATION MEETING DATE: 06/06/2007 | ||||
| TICKER: DNDN SECURITY ID: 24823Q107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT GERARDO CANET AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT B. DZIURZYNSKI, D.P.A. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT DOUGLAS G. WATSON AS A DIRECTOR | Management | For | For |
| 2 | APPROVAL OF THE RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT YEAR. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ELAN CORPORATION, PLC MEETING DATE: 05/24/2007 | ||||
| TICKER: ELN SECURITY ID: 284131208 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO RECEIVE AND CONSIDER THE FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2006 TOGETHER WITH THE REPORTS OF THE DIRECTORS AND AUDITORS THEREON. | Management | For | For |
| 2 | TO RE-ELECT MR. LAURENCE CROWLEY WHO RETIRES FROM THE BOARD IN ACCORDANCE WITH THE COMBINED CODE. | Management | For | For |
| 3 | TO RE-ELECT MR. KYRAN MCLAUGHLIN WHO RETIRES FROM THE BOARD BY ROTATION IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION. | Management | For | For |
| 4 | TO RE-ELECT DR. DENNIS SELKOE WHO RETIRES FROM THE BOARD BY ROTATION IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION. | Management | For | For |
| 5 | TO ELECT MR. WILLIAM ROHN WHO RETIRES FROM THE BOARD IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION. | Management | For | For |
| 6 | TO AUTHORISE THE DIRECTORS TO FIX THE REMUNERATION OF THE AUDITORS. | Management | For | For |
| 7 | TO AUTHORISE THE DIRECTORS TO ISSUE SECURITIES. | Management | For | For |
| 8 | TO AUTHORISE THE DISAPPLICATION OF PRE-EMPTION RIGHTS ON THE ALLOTMENT OF UP TO 40 MILLION SHARES FOR CASH. | Management | For | For |
| 9 | TO AUTHORISE THE COMPANY TO MAKE MARKET PURCHASES OF ITS OWN SHARES. | Management | For | For |
| 10 | TO SET THE RE-ISSUE PRICE RANGE FOR TREASURY SHARES. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ENCYSIVE PHARMACEUTICALS INC. MEETING DATE: 05/09/2007 | ||||
| TICKER: ENCY SECURITY ID: 29256X107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JOHN M. PIETRUSKI AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT RON J. ANDERSON AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT J. KEVIN BUCHI AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT ROBERT J. CRUIKSHANK AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT JOHN H. DILLON, II AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT RICHARD A.F. DIXON AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT BRUCE D. GIVEN AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT SUZANNE OPARIL AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT JAMES A. THOMSON AS A DIRECTOR | Management | For | For |
| 1. 10 | ELECT JAMES T. WILLERSON AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO ADOPT THE 2007 INCENTIVE PLAN. | Management | For | Against |
| 3 | PROPOSAL TO RATIFY KPMG LLP AS OUR INDEPENDENT AUDITOR FOR 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ENZON PHARMACEUTICALS, INC. MEETING DATE: 05/16/2007 | ||||
| TICKER: ENZN SECURITY ID: 293904108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JEFFREY H. BUCHALTER AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT GORAN A. ANDO, M.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT VICTOR P. MICATI AS A DIRECTOR | Management | For | For |
| 2 | APPROVAL OF THE ADOPTION OF THE 2007 EMPLOYEE STOCK PURCHASE PLAN. | Management | For | Against |
| 3 | RATIFICATION OF THE SELECTION OF KPMG LLP TO AUDIT THE CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: EXELIXIS, INC. MEETING DATE: 05/01/2007 | ||||
| TICKER: EXEL SECURITY ID: 30161Q104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ALAN M. GARBER AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT VINCENT T. MARCHESI AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT CARL B. FELDBAUM AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS EXELIXIS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 28, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: GEN-PROBE INCORPORATED MEETING DATE: 05/31/2007 | ||||
| TICKER: GPRO SECURITY ID: 36866T103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | ELECTION OF DIRECTOR: MAE C. JEMISON, M.D. | Management | For | Against |
| 2 | ELECTION OF DIRECTOR: ARMIN M. KESSLER | Management | For | For |
| 3 | TO APPROVE THE GEN-PROBE INCORPORATED 2007 EXECUTIVE BONUS PLAN. | Management | For | For |
| 4 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: GENENTECH, INC. MEETING DATE: 04/20/2007 | ||||
| TICKER: DNA SECURITY ID: 368710406 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT HERBERT W. BOYER AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT WILLIAM M. BURNS AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ERICH HUNZIKER AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT JONATHAN K.C. KNOWLES AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT ARTHUR D. LEVINSON AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT DEBRA L. REED AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT CHARLES A. SANDERS AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GENENTECH FOR THE YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: GENZYME CORPORATION MEETING DATE: 05/24/2007 | ||||
| TICKER: GENZ SECURITY ID: 372917104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT DOUGLAS A. BERTHIAUME AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT GAIL K. BOUDREAUX AS A DIRECTOR | Management | For | For |
| 2 | A PROPOSAL TO AMEND THE 2004 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK COVERED BY THE PLAN BY 3,500,000 SHARES AND TO MERGE OUR 1997 EQUITY INCENTIVE PLAN INTO THE 2004 PLAN. | Management | For | Against |
| 3 | A PROPOSAL TO APPROVE THE 2007 DIRECTOR EQUITY PLAN. | Management | For | Against |
| 4 | A PROPOSAL TO AMEND THE 1999 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK COVERED BY THE PLAN BY 1,500,000 SHARES. | Management | For | Against |
| 5 | A PROPOSAL TO AMEND OUR BYLAWS TO PROVIDE FOR MAJORITY VOTING FOR THE ELECTION OF DIRECTORS IN UNCONTESTED ELECTIONS. | Management | For | For |
| 6 | A PROPOSAL TO RATIFY THE SELECTION OF INDEPENDENT AUDITORS FOR 2007. | Management | For | For |
| 7 | A SHAREHOLDER PROPOSAL THAT EXECUTIVE SEVERANCE AGREEMENTS BE APPROVED BY SHAREHOLDERS. | Shareholder | Against | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: GILEAD SCIENCES, INC. MEETING DATE: 05/09/2007 | ||||
| TICKER: GILD SECURITY ID: 375558103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT PAUL BERG AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT JOHN F. COGAN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ETIENNE F. DAVIGNON AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT JAMES M. DENNY AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT CARLA A. HILLS AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT JOHN W. MADIGAN AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT JOHN C. MARTIN AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT GORDON E. MOORE AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT NICHOLAS G. MOORE AS A DIRECTOR | Management | For | For |
| 1. 10 | ELECT GAYLE E. WILSON AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GILEAD FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| 3 | TO APPROVE THE PROPOSED AMENDMENT TO GILEAD S 2004 EQUITY INCENTIVE PLAN. | Management | For | For |
| 4 | TO APPROVE THE PROPOSED AMENDMENT TO GILEAD S EMPLOYEE STOCK PURCHASE PLAN. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: GTX, INC. MEETING DATE: 05/02/2007 | ||||
| TICKER: GTXI SECURITY ID: 40052B108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT MICHAEL G. CARTER, M.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT J.R. HYDE, III AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT TIMOTHY R.G. SEAR AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT MITCH S. STEINER, M.D. AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS GTX S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: HALOZYME THERAPEUTICS, INC. MEETING DATE: 05/15/2007 | ||||
| TICKER: HTI SECURITY ID: 40637H109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ROBERT L. ENGLER AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT GREGORY I. FROST AS A DIRECTOR | Management | For | Withhold |
| 1. 3 | ELECT CONNIE L. MATSUI AS A DIRECTOR | Management | For | Withhold |
| 2 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: HUMAN GENOME SCIENCES, INC. MEETING DATE: 05/02/2007 | ||||
| TICKER: HGSI SECURITY ID: 444903108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT RICHARD J DANZIG AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT JURGEN DREWS, M.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT A N JERRY KARABELAS PHD AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE THE ADOPTION OF THE COMPANY S EMPLOYEE STOCK PURCHASE PLAN. | Management | For | For |
| 3 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: IMCLONE SYSTEMS INCORPORATED MEETING DATE: 09/20/2006 | ||||
| TICKER: IMCL SECURITY ID: 45245W109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ANDREW G. BODNAR AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT WILLIAM W. CROUSE AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ALEXANDER J. DENNER AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT VINCENT T. DEVITA, JR. AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT JOHN A. FAZIO AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT JOSEPH L. FISCHER AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT CARL C. ICAHN AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT DAVID M. KIES AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT WILLIAM R. MILLER AS A DIRECTOR | Management | For | For |
| 1. 10 | ELECT RICHARD C. MULLIGAN AS A DIRECTOR | Management | For | For |
| 1. 11 | ELECT DAVID SIDRANSKY AS A DIRECTOR | Management | For | For |
| 1. 12 | ELECT CHARLES WOLER AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF THE APPOINTMENT OF KPMG LLP TO SERVE AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2006. | Management | For | For |
| 3 | APPROVAL OF THE IMCLONE SYSTEMS INCORPORATED 2006 STOCK INCENTIVE PLAN. | Management | For | Against |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: INFINITY PHARMACEUTICALS, INC. MEETING DATE: 05/30/2007 | ||||
| TICKER: INFI SECURITY ID: 45665G303 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | ELECTION OF CLASS I DIRECTOR: ERIC S. LANDER, PH.D. | Management | For | For |
| 2 | ELECTION OF CLASS I DIRECTOR: FRANKLIN H. MOSS, PH.D. | Management | For | For |
| 3 | ELECTION OF CLASS I DIRECTOR: HERM ROSENMAN | Management | For | For |
| 4 | ELECTION OF CLASS I DIRECTOR: JAMES B. TANANBAUM, PH.D. | Management | For | For |
| 5 | TO APPROVE THE AMENDMENT AND RESTATEMENT OF OUR CERTIFICATE OF INCORPORATION TO DECLASSIFY OUR BOARD AND PROVIDE FOR THE ANNUAL ELECTION OF DIRECTORS BEGINNING AT THE 2008 ANNUAL MEETING OF STOCKHOLDERS AND TO ALLOW FOR THE REMOVAL OF DIRECTORS WITHOUT CAUSE AND CERTAIN OTHER CHANGES. | Management | For | For |
| 6 | TO APPROVE THE AMENDMENT OF ARTICLE III, SECTIONS 1 AND 13 AND ARTICLE X, SECTION 1(B) AND (C) OF OUR BY-LAWS TO DECLASSIFY OUR BOARD AND PROVIDE FOR THE ANNUAL ELECTION OF DIRECTORS BEGINNING AT THE 2008 ANNUAL MEETING OF STOCKHOLDERS AND TO ALLOW FOR THE REMOVAL OF DIRECTORS WITHOUT CAUSE AND CERTAIN OTHER CHANGES. | Management | For | For |
| 7 | TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ISIS PHARMACEUTICALS, INC. MEETING DATE: 05/17/2007 | ||||
| TICKER: ISIS SECURITY ID: 464330109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT STANLEY T. CROOKE AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT JOSEPH KLEIN, III AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JOHN C. REED AS A DIRECTOR | Management | For | Withhold |
| 2 | TO RATIFY THE AUDIT COMMITTEE S SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS FOR OUR 2007 FISCAL YEAR. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ITHAKA ACQUISITION CORP. MEETING DATE: 06/21/2007 | ||||
| TICKER: ITHK SECURITY ID: 465707107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO ADOPT THE AGREEMENT AND PLAN OF MERGER, AS AMENDED. | Management | For | For |
| 2 | IF YOU HAVE VOTED AGAINST PROPOSAL 1 AND ARE EXERCISING YOUR CONVERSION RIGHTS, YOU MUST CHECK THE AGAINST BOX. PLEASE CALL PAUL BROOKE AT 212-380-2242 FOR ADDITIONAL INFORMATION ON EXERCISING YOUR CONVERSION RIGHTS. | Management | Unknown | Abstain |
| 3 | TO APPROVE AN AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO CHANGE THE NAME OF ITHAKA TO ALSIUS CORPORATION. | Management | For | For |
| 4 | THE APPROVAL OF AN AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES. | Management | For | For |
| 5 | THE APPROVAL OF AN AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO REMOVE THE PREAMBLE AND SECTIONS A THROUGH D, AND TO REDESIGNATE SECTION E OF ARTICLE SIXTH AS ARTICLE SIXTH. | Management | For | For |
| 6 | TO APPROVE THE ITHAKA 2006 EQUITY INCENTIVE PLAN. | Management | For | Against |
| 7 | A PROPOSAL TO ADJOURN THE SPECIAL MEETING, IF NECESSARY, TO PERMIT FURTHER SOLICITATION AND VOTE OF PROXIES. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: LIGAND PHARMACEUTICALS INCORPORATED MEETING DATE: 02/12/2007 | ||||
| TICKER: LGND SECURITY ID: 53220K207 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO APPROVE THE SALE OF ALL OR SUBSTANTIALLY ALL OF OUR ASSETS UNDER DELAWARE LAW THROUGH THE SALE OF OUR RIGHTS IN AND TO AVINZA (MORPHINE SULFATE EXTENDED-RELEASE CAPSULES), IN THE UNITED STATES, ITS TERRITORIES AND CANADA, PURSUANT TO THE ASSET PURCHASE AGREEMENT. | Management | For | For |
| 2 | TO AMEND LIGAND S 2002 STOCK INCENTIVE PLAN TO ALLOW EQUITABLE ADJUSTMENTS TO BE MADE TO OPTIONS OUTSTANDING UNDER THE PLAN IN THE EVENT OF THE PAYMENT OF A LARGE NON-RECURRING CASH DIVIDEND. | Management | For | Against |
| 3 | TO APPROVE THE ADJOURNMENT OF THE SPECIAL MEETING, IF NECESSARY, TO FACILITATE THE APPROVAL OF PROPOSALS 1 OR 2, INCLUDING TO PERMIT THE SOLICITATION OF ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES AT THE TIME OF THE SPECIAL MEETING TO ESTABLISH A QUORUM OR TO APPROVE 1 OR 2. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: LIGAND PHARMACEUTICALS INCORPORATED MEETING DATE: 05/31/2007 | ||||
| TICKER: LGND SECURITY ID: 53220K207 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JASON ARYEH AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT TODD C. DAVIS AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ELIZABETH M. GREETHAM AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT JOHN L. HIGGINS AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT DAVID M. KNOTT AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT JOHN W. KOZARICH AS A DIRECTOR | Management | For | Withhold |
| 1. 7 | ELECT JEFFREY R. PERRY AS A DIRECTOR | Management | For | Withhold |
| 2 | AMENDMENT OF 2002 STOCK INCENTIVE PLAN | Management | For | Against |
| 3 | RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MANNKIND CORPORATION MEETING DATE: 05/24/2007 | ||||
| TICKER: MNKD SECURITY ID: 56400P201 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ALFRED E. MANN AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT HAKAN S. EDSTROM AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT BARRY E. COHEN AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT RONALD J. CONSIGLIO AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT MICHAEL A. FRIEDMAN, MD AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT HEATHER MAY MURREN AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT KENT KRESA AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT DAVID H. MACCALLUM AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT HENRY L. NORDHOFF AS A DIRECTOR | Management | For | For |
| 2 | INCREASE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 90 MILLION TO 150 MILLION | Management | For | For |
| 3 | RATIFICATION OF DELOITTE & TOUCHE LLP AS INDEPENDENT AUDITORS | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MARTEK BIOSCIENCES CORPORATION MEETING DATE: 03/15/2007 | ||||
| TICKER: MATK SECURITY ID: 572901106 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | ELECTION OF DIRECTOR: DOUGLAS J. MACMASTER, JR. | Management | For | For |
| 2 | ELECTION OF DIRECTOR: EUGENE H. ROTBERG | Management | For | For |
| 3 | TO APPROVE A PROPOSED AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO DECLASSIFY OUR BOARD SO THAT, BEGINNING IN 2008, DIRECTORS WILL BE ELECTED FOR ONE-YEAR TERMS | Management | For | For |
| 4 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR 2007 | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MEDAREX, INC. MEETING DATE: 05/17/2007 | ||||
| TICKER: MEDX SECURITY ID: 583916101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT MR. ABHIJEET J. LELE* AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT MR. IRWIN LERNER* AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT DR. JULIUS A. VIDA* AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT MR. R.C. DINERSTEIN** AS A DIRECTOR | Management | For | For |
| 2 | THE RATIFICATION OF THE SELECTION BY THE BOARD OF ERNST & YOUNG LLP AS MEDAREX S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MEDIVATION INC MEETING DATE: 05/30/2007 | ||||
| TICKER: MDVN SECURITY ID: 58501N101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT DANIEL D. ADAMS AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT GREGORY H. BAILEY, M.D. AS A DIRECTOR | Management | For | Withhold |
| 1. 3 | ELECT KIM D. BLICKENSTAFF AS A DIRECTOR | Management | For | Withhold |
| 1. 4 | ELECT DAVID T. HUNG, M.D. AS A DIRECTOR | Management | For | Withhold |
| 1. 5 | ELECT W. ANTHONY VERNON AS A DIRECTOR | Management | For | Withhold |
| 2 | TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP, AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| 3 | TO APPROVE THE AMENDED AND RESTATED 2004 EQUITY INCENTIVE AWARD PLAN. | Management | For | Against |
| 4 | TO TRANSACT SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENT OR POSTPONEMENT THEREOF. | Management | For | Abstain |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MOMENTA PHARMACEUTICALS, INC. MEETING DATE: 06/13/2007 | ||||
| TICKER: MNTA SECURITY ID: 60877T100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT PETER BARRETT AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT RAM SASISEKHARAN AS A DIRECTOR | Management | For | Withhold |
| 1. 3 | ELECT BENNETT M. SHAPIRO AS A DIRECTOR | Management | For | Withhold |
| 2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: MYRIAD GENETICS, INC. MEETING DATE: 11/16/2006 | ||||
| TICKER: MYGN SECURITY ID: 62855J104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ROBERT S. ATTIYEH AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT JOHN T. HENDERSON, M.D. AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO AMEND THE 2003 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK OPTION PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE THEREUNDER BY 1,500,000 SHARES. | Management | For | Against |
| 3 | PROPOSAL TO AMEND THE EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE THEREUNDER BY 400,000 SHARES. | Management | For | Against |
| 4 | PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: NEUROCRINE BIOSCIENCES, INC. MEETING DATE: 06/01/2007 | ||||
| TICKER: NBIX SECURITY ID: 64125C109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT CORINNE H. LYLE AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT RICHARD F. POPS AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT STEPHEN A. SHERWIN AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN AMENDMENT TO THE COMPANY S 2003 INCENTIVE STOCK PLAN, AS AMENDED, TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE THEREUNDER FROM 4,300,000 TO 4,800,000. | Management | For | For |
| 3 | TO CONSIDER A STOCKHOLDER PROPOSAL TO DECLASSIFY THE BOARD OF DIRECTORS. | Shareholder | Against | For |
| 4 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: NOVACEA, INC. MEETING DATE: 06/08/2007 | ||||
| TICKER: NOVC SECURITY ID: 66987B103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JAMES C. BLAIR AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT CAMILLE D. SAMUELS AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF NOVACEA, INC. FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: OMRIX BIOPHARMACEUTICALS, INC. MEETING DATE: 05/31/2007 | ||||
| TICKER: OMRI SECURITY ID: 681989109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT FREDRIC D. PRICE AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT LARRY ELLBERGER AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT BERNARD HOROWITZ, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT KEVIN RAKIN AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT PHILIPPE ROMAGNOLI AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT STEVEN ST. PETER, M.D. AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT ROBERT TAUB AS A DIRECTOR | Management | For | For |
| 2 | THE RATIFICATION OF THE SELECTION BY THE BOARD OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL, AS OMRIX INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ONYX PHARMACEUTICALS, INC. MEETING DATE: 05/25/2007 | ||||
| TICKER: ONXX SECURITY ID: 683399109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT CORINNE H. LYLE AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT THOMAS G. WIGGANS AS A DIRECTOR | Management | For | For |
| 2 | TO APPROVE AN AMENDMENT TO THE COMPANY S 2005 EQUITY INCENTIVE PLAN TO INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THAT PLAN BY 1,600,000 SHARES. | Management | For | For |
| 3 | TO APPROVE AN AMENDMENT TO THE COMPANY S 1996 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THAT PLAN BY 500,000 SHARES. | Management | For | For |
| 4 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: OSI PHARMACEUTICALS, INC. MEETING DATE: 06/13/2007 | ||||
| TICKER: OSIP SECURITY ID: 671040103 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT ROBERT A. INGRAM AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT COLIN GODDARD, PHD AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT SANTO J. COSTA AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT DARYL K. GRANNER, M.D. AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT JOSEPH KLEIN, III AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT KENNETH B. LEE, JR. AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT VIREN MEHTA AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT DAVID W. NIEMIEC AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT HERBERT PINEDO, MD, PHD AS A DIRECTOR | Management | For | For |
| 1. 10 | ELECT KATHARINE B. STEVENSON AS A DIRECTOR | Management | For | For |
| 1. 11 | ELECT JOHN P. WHITE AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO AMEND THE OSI PHARMACEUTICALS, INC. AMENDED AND RESTATED STOCK INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE UNDER THE PLAN. | Management | For | For |
| 3 | PROPOSAL TO RATIFY THE APPOINTMENT OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE CORPORATION FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: PDL BIOPHARMA, INC. MEETING DATE: 06/20/2007 | ||||
| TICKER: PDLI SECURITY ID: 69329Y104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT LAURENCE J. KORN, PH.D. AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT SAMUEL BRODER, M.D. AS A DIRECTOR | Management | For | Withhold |
| 2 | TO APPROVE AN AMENDMENT TO THE COMPANY S 2005 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 2,900,000 SHARES. | Management | For | Against |
| 3 | TO APPROVE AN AMENDMENT TO THE COMPANY S 1993 EMPLOYEE STOCK PURCHASE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 500,000 SHARES. | Management | For | For |
| 4 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: PHARMION CORPORATION MEETING DATE: 06/06/2007 | ||||
| TICKER: PHRM SECURITY ID: 71715B409 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT BRIAN G. ATWOOD AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT M. JAMES BARRETT AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT EDWARD J. MCKINLEY AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS PHARMION CORPORATION S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007 | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: QIAGEN N.V. MEETING DATE: 06/20/2007 | ||||
| TICKER: QGEN SECURITY ID: N72482107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | PROPOSAL TO ADOPT THE ANNUAL ACCOUNTS FOR THE YEAR ENDED DECEMBER 31, 2006 ( FISCAL YEAR 2006 ). | Management | For | For |
| 2 | PROPOSAL TO APPROVE THE PERFORMANCE OF THE MANAGING BOARD DURING FISCAL YEAR 2006, INCLUDING A DISCHARGE FROM LIABILITY WITH RESPECT TO THE EXERCISE OF THEIR DUTIES DURING FISCAL YEAR 2006. | Management | For | For |
| 3 | PROPOSAL TO APPROVE THE PERFORMANCE OF THE SUPERVISORY BOARD DURING FISCAL YEAR 2006, INCLUDING A DISCHARGE FROM LIABILITY. | Management | For | For |
| 4 | PROPOSAL TO (RE-)APPOINT SIX SUPERVISORY DIRECTORS OF THE COMPANY FOR A TERM ENDING ON THE DATE OF THE ANNUAL GENERAL MEETING IN 2008. | Management | For | For |
| 5 | PROPOSAL TO REAPPOINT FOUR MANAGING DIRECTORS OF THE COMPANY FOR A TERM ENDING ON THE DATE OF THE ANNUAL GENERAL MEETING IN 2008. | Management | For | For |
| 6 | PROPOSAL TO REAPPOINT ERNST & YOUNG ACCOUNTANTS AS AUDITORS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| 7 | PROPOSAL TO EXTEND THE AUTHORITY OF THE MANAGING BOARD UNTIL DECEMBER 20, 2008, AS MORE FULLY DESCRIBED IN THE STATEMENT. | Management | For | For |
| 8 | PROPOSAL TO APPROVE AN AMENDMENT TO THE COMPANY S AMENDED AND RESTATED 2005 STOCK PLAN (THE AMENDED PLAN ). | Management | For | Abstain |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: QUIDEL CORPORATION MEETING DATE: 05/07/2007 | ||||
| TICKER: QDEL SECURITY ID: 74838J101 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT THOMAS D. BROWN AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT RODNEY F. DAMMEYER AS A DIRECTOR | Management | For | Withhold |
| 1. 3 | ELECT D.S. HARRINGTON, M.D. AS A DIRECTOR | Management | For | Withhold |
| 1. 4 | ELECT CAREN L. MASON AS A DIRECTOR | Management | For | Withhold |
| 1. 5 | ELECT M.L. POLAN, MD,PHD,MPH AS A DIRECTOR | Management | For | Withhold |
| 1. 6 | ELECT MARK A. PULIDO AS A DIRECTOR | Management | For | Withhold |
| 1. 7 | ELECT JACK W. SCHULER AS A DIRECTOR | Management | For | Withhold |
| 2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| 3 | TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE QUIDEL CORPORATION 2001 EQUITY INCENTIVE PLAN TO INCREASE THE AUTHORIZED SHARES, AMONG OTHER MATTERS. | Management | For | Against |
| 4 | TO APPROVE THE PERFORMANCE GOALS USED TO ESTABLISH COMPENSATION PROGRAMS AND AWARDS UNDER THE QUIDEL CORPORATION 2001 EQUITY INCENTIVE PLAN. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: REGENERON PHARMACEUTICALS, INC. MEETING DATE: 06/08/2007 | ||||
| TICKER: REGN SECURITY ID: 75886F107 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT L S SCHLEIFER, MD PHD AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT ERIC M. SHOOTER, PHD AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT G D YANCOPOULOS, MD PHD AS A DIRECTOR | Management | For | For |
| 2 | PROPOSAL TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ROSETTA GENOMICS LTD MEETING DATE: 05/30/2007 | ||||
| TICKER: ROSG SECURITY ID: M82183100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO ELECT MS. TALI YARON-ELDAR AND MR. GERALD DOGON AS EXTERNAL DIRECTORS OF THE COMPANY. | Management | For | For |
| 2 | TO AMEND OUR ARTICLES OF ASSOCIATION TO AMEND NOTICE PROVISIONS IN ACCORDANCE WITH THE ISRAEL COMPANIES LAW. | Management | For | Against |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: SEPRACOR INC. MEETING DATE: 05/15/2007 | ||||
| TICKER: SEPR SECURITY ID: 817315104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT DIGBY BARRIOS AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT ALAN STEIGROD AS A DIRECTOR | Management | For | Withhold |
| 2 | TO APPROVE AN AMENDMENT TO SEPRACOR S 2000 STOCK INCENTIVE PLAN (THE 2000 PLAN ) INCREASING FROM 11,500,000 TO 13,500,000 THE NUMBER OF SHARES OF COMMON STOCK OF SEPRACOR INC. RESERVED FOR ISSUANCE UNDER THE 2000 PLAN. | Management | For | For |
| 3 | TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS SEPRACOR S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: TECHNE CORPORATION MEETING DATE: 10/26/2006 | ||||
| TICKER: TECH SECURITY ID: 878377100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO SET THE NUMBER OF DIRECTORS AT SEVEN | Management | For | For |
| 2. 1 | ELECT THOMAS E. OLAND AS A DIRECTOR | Management | For | For |
| 2. 2 | ELECT ROGER C. LUCAS, PH.D. AS A DIRECTOR | Management | For | For |
| 2. 3 | ELECT HOWARD V. O'CONNELL AS A DIRECTOR | Management | For | For |
| 2. 4 | ELECT G. ARTHUR HERBERT AS A DIRECTOR | Management | For | For |
| 2. 5 | ELECT R.C. STEER, M.D., PH.D. AS A DIRECTOR | Management | For | For |
| 2. 6 | ELECT ROBERT V. BAUMGARTNER AS A DIRECTOR | Management | For | For |
| 2. 7 | ELECT C.A. DINARELLO, M.D. AS A DIRECTOR | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: TERCICA, INC. MEETING DATE: 10/12/2006 | ||||
| TICKER: TRCA SECURITY ID: 88078L105 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1 | TO APPROVE THE ISSUANCE OF SECURITIES TO IPSEN, S.A. OR ITS DESIGNATED AFFILIATE IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED BY THE STOCK PURCHASE AND MASTER TRANSACTION AGREEMENT, DATED JULY 18, 2006, BETWEEN TERCICA AND IPSEN S.A., AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT. | Management | For | For |
| 2 | TO APPROVE AMENDMENTS TO TERCICA S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION AND AMENDED AND RESTATED BYLAWS, AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT. | Management | For | For |
| 3 | TO APPROVE ADDITIONAL AMENDMENTS TO TERCICA S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT. | Management | For | For |
| 4 | TO APPROVE THE ADOPTION BY TERCICA OF A RIGHTS AGREEMENT IMPLEMENTING A STOCKHOLDER RIGHTS PLAN, AS DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT. | Management | For | Against |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: THERAVANCE, INC. MEETING DATE: 04/25/2007 | ||||
| TICKER: THRX SECURITY ID: 88338T104 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT P. ROY VAGELOS, M.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT RICK E. WINNINGHAM AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JEFFREY M. DRAZAN AS A DIRECTOR | Management | For | For |
| 1. 4 | ELECT ROBERT V. GUNDERSON, JR AS A DIRECTOR | Management | For | For |
| 1. 5 | ELECT ARNOLD J. LEVINE, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 6 | ELECT EVE E. SLATER, M.D. AS A DIRECTOR | Management | For | For |
| 1. 7 | ELECT WILLIAM H. WALTRIP AS A DIRECTOR | Management | For | For |
| 1. 8 | ELECT G.M. WHITESIDES, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 9 | ELECT WILLIAM D. YOUNG AS A DIRECTOR | Management | For | For |
| 2 | APPROVE AN AMENDMENT TO THE THERAVANCE, INC. 2004 EQUITY INCENTIVE PLAN (THE INCENTIVE PLAN ) TO, AMONG OTHER THINGS, INCREASE THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE UNDER THE INCENTIVE PLAN FROM 3,700,000 TO 7,200,000 SHARES, AS DESCRIBED IN THE PROXY STATEMENT. | Management | For | Against |
| 3 | APPROVE AN AMENDMENT TO THE COMPANY S RESTATED CERTIFICATE OF INCORPORATION TO ENABLE THE COMPANY TO ISSUE SHARES OF CLASS A COMMON STOCK AND COMMON STOCK TO GLAXOSMITHKLINE PLC OR ITS DESIGNATED AFFILIATE IN THE EVENT OF THE CALL OR THE PUT AND TO ISSUE COMMON STOCK WITH RESPECT TO ANY STOCK DIVIDENDS ON CLASS A COMMON STOCK AFTER THE CALL AND PUT DATES. | Management | For | For |
| 4 | RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: TRUBION PHARMACEUTICALS INC. MEETING DATE: 05/25/2007 | ||||
| TICKER: TRBN SECURITY ID: 89778N102 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT STEVEN GILLIS, PH.D. AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT PATRICK J. HERON AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: UNITED THERAPEUTICS CORPORATION MEETING DATE: 06/26/2007 | ||||
| TICKER: UTHR SECURITY ID: 91307C102 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT CHRISTOPHER CAUSEY AS A DIRECTOR | Management | For | Withhold |
| 1. 2 | ELECT R. PAUL GRAY AS A DIRECTOR | Management | For | Withhold |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: VANDA PHARMACEUTICALS, INC. MEETING DATE: 05/16/2007 | ||||
| TICKER: VNDA SECURITY ID: 921659108 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT DR. JAMES B. TANANBAUM AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT MR. DAVID RAMSAY AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT MR. H. THOMAS WATKINS AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: VERTEX PHARMACEUTICALS INCORPORATED MEETING DATE: 05/31/2007 | ||||
| TICKER: VRTX SECURITY ID: 92532F100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT JOSHUA S. BOGER AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT CHARLES A. SANDERS AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT ELAINE S. ULLIAN AS A DIRECTOR | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: VIACELL, INC. MEETING DATE: 05/30/2007 | ||||
| TICKER: VIAC SECURITY ID: 92554J105 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT MARC D. BEER AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT VAUGHN M. KAILIAN AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT JAMES SIGLER AS A DIRECTOR | Management | For | For |
| 2 | RATIFICATION OF THE SELECTION OF PRICEWATERHOUSECOOPERS, LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007 | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: XENOPORT, INC. MEETING DATE: 05/30/2007 | ||||
| TICKER: XNPT SECURITY ID: 98411C100 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT PAUL L. BERNS AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT JOHN G. FREUND, M.D. AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT KENNETH J. NUSSBACHER AS A DIRECTOR | Management | For | For |
| 2 | TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE COMPANY S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2007. | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
| ISSUER NAME: ZYMOGENETICS, INC. MEETING DATE: 06/21/2007 | ||||
| TICKER: ZGEN SECURITY ID: 98985T109 | ||||
| Proposal No | Proposal | Proposed By | Management Recommendation | Vote Cast |
| 1. 1 | ELECT BRUCE L.A. CARTER, PHD AS A DIRECTOR | Management | For | For |
| 1. 2 | ELECT JAMES A. HARPER AS A DIRECTOR | Management | For | For |
| 1. 3 | ELECT EDWARD E. PENHOET, PHD AS A DIRECTOR | Management | For | For |
| 2 | APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP | Management | For | For |
| Fidelity displays agenda items and descriptions as they are provided by the issuer and the vote processing agent. These descriptions may include special characters such as asterisks. Generally, asterisks refer to the class of director or stock or indicate notice of voting instructions. | ||||
POWER OF ATTORNEY
I, the undersigned Treasurer of the following investment companies:
Colchester Street Trust Fidelity Aberdeen Street Trust Fidelity Advisor Series I Fidelity Advisor Series II Fidelity Advisor Series IV Fidelity Advisor Series VII Fidelity Advisor Series VIII Fidelity Beacon Street Trust Fidelity Boylston Street Trust Fidelity California Municipal Trust Fidelity California Municipal Trust II Fidelity Capital Trust Fidelity Central Investment Portfolios LLC Fidelity Central Investment Portfolios II LLC Fidelity Charles Street Trust Fidelity Commonwealth Trust Fidelity Concord Street Trust Fidelity Congress Street Trust Fidelity Contrafund Fidelity Court Street Trust Fidelity Court Street Trust II Fidelity Covington Trust Fidelity Destiny Portfolios Fidelity Devonshire Trust Fidelity Exchange Fund Fidelity Financial Trust Fidelity Fixed-Income Trust Fidelity Garrison Street Trust Fidelity Hanover Street Trust | Fidelity Hastings Street Trust Fidelity Hereford Street Trust Fidelity Income Fund Fidelity Investment Trust Fidelity Magellan Fund Fidelity Massachusetts Municipal Trust Fidelity Money Market Trust Fidelity Mt. Vernon Street Trust Fidelity Municipal Trust Fidelity Municipal Trust II Fidelity New York Municipal Trust Fidelity New York Municipal Trust II Fidelity Oxford Street Trust Fidelity Phillips Street Trust Fidelity Puritan Trust Fidelity Revere Street Trust Fidelity School Street Trust Fidelity Securities Fund Fidelity Select Portfolios Fidelity Summer Street Trust Fidelity Trend Fund Fidelity Union Street Trust Fidelity Union Street Trust II Newbury Street Trust Variable Insurance Products Fund Variable Insurance Products Fund II Variable Insurance Products Fund III Variable Insurance Products Fund IV Variable Insurance Products Fund V |
plus any other investment company for which Fidelity Management & Research Company or an affiliate acts as investment adviser and for which the undersigned individual serves as Treasurer (collectively, the "Funds"), hereby constitute and appoint Nicholas Steck and Claire Walpole my true and lawful attorneys-in-fact, each of them singly, with full power of substitution, and with full power to sign for me and in my name in the appropriate capacities, all Reports of the Proxy Voting Records of the Funds on Form N-PX under the Investment Company Act of 1940, as amended (the "Act"), or any successor thereto, and any supplements or other instruments in connection therewith, and generally to do all such things in my name and behalf in connection therewith as said attorneys-in-fact deem necessary or appropriate to cause such Form to be completed and filed in accordance with the Act and all related requirements of the Securities and Exchange Commission. I hereby ratify and confirm all that said attorneys-in-fact or their substitute may do or cause to be done by virtue hereof. This power of attorney is effective for all documents filed on or after August 1, 2007.
WITNESS my hand on this 10th of July 2007.
/s/ Kimberley Monasterio
Kimberley Monasterio
Treasurer